93
Views
10
CrossRef citations to date
0
Altmetric
Review

The emerging link between nutrition, inflammation and atherosclerosis

, &
Pages 385-393 | Published online: 10 Jan 2014

References

  • Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation105, 1135–1143 (2002).
  • Kesteloot H. Alcohol intake and markers of inflammation. Eur. Heart J.25, 2075–2076 (2004).
  • Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation107, 391–397 (2003).
  • Ridker PM, Cannon CP, Morrow D et al. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med.352, 20–28 (2005).
  • Nissen SE, Tuzcu EM, Schoenhagen P et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N. Engl. J. Med.352, 29–38 (2005).
  • Albert MA, Danielson E, Rifai N, Ridker PM; for the PRINCE Investigators. Effect of statin therapy on C-reactive protein levels – the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study. JAMA286, 64–70 (2001).
  • Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA Study. J. Am. Coll. Cardiol.44, 152–158 (2004).
  • Gao X, Bermudez OI, Tucker KL. Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J. Nutr.134, 913–918 (2004).
  • Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Rönnemaa T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. JAMA287, 598–605 (2002).
  • Kris-Etherton PM, Lichtenstein AH, Howard BV, Steinberg D, Witztum JL. Antioxidant vitamin supplements and cardiovascular disease. Circulation110, 637–641 (2004).
  • Esposito K, Marfella R, Ciotola M et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292, 1440–1446 (2004).
  • Nantel G. Glycemic carbohydrate: an international perspective. Nutr. Rev. 61, S34–S39 (2003).
  • Granfeldt Y, Bjorck I, Hagander B. On the importance of processing conditions, product thickness and egg addition for the glycaemic and hormonal responses to pasta: a comparison with bread made from ‘pasta ingredients.’ Eur. J. Clin. Nutr.45, 489–499 (1991).
  • Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA292, 2482–2490 (2004).
  • Esposito K, Nappo F, Marfella R et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation106, 2067–2077 (2002).
  • Pawlak DB, Kushner JA, Ludwig DS. Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals. Lancet364, 778–785 (2004).
  • Pereira MA, O’Reilly E, Augustsson K et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch. Intern. Med.164, 370–376 (2004).
  • King DE, Egan BM, Geesey ME. Relation of dietary fat and fiber to elevation of C-reactive protein. Am. J. Cardiol.92, 1335–1339 (2003).
  • Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation107, 443–447 (2003).
  • Imhof A, Froelich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet357, 763–767 (2001).
  • Volpato S, Pahor M, Ferrucci L et al. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation109, 607–612 (2004).
  • Imhof A, Woodward M, Doering A et al. Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur. Heart J.25, 2092–2100 (2004).
  • van der Gaag MS, van Tol A, Vermunt SH, Scheek LM, Schaafsma G, Hendriks HF. Alcohol consumption stimulates early steps in reverse cholesterol transport. J. Lipid Res.42, 2077–2083 (2001).
  • Goldberg IJ, Mosca L, Piano MR, Fisher EA. Wine and your heart – a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Circulation103, 472–475 (2001).
  • Retterstol L, Berge KE, Braaten O, Eikvar L, Pedersen TR, Sandvik L. A daily glass of red wine: does it affect markers of inflammation? Alcohol40, 102–105 (2005).
  • Williams MJ, Sutherland WH, Whelan AP, McCormick MP, de Jong SA. Acute effect of drinking red and white wines on circulating levels of inflammation-sensitive molecules in men with coronary artery disease. Metabolism53, 318–323 (2004).
  • Teragawa H, Fukuda Y, Matsuda K et al. Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis165, 145–152 (2002).
  • Zureik M, Gariepy J, Courbon D et al. Alcohol consumption and carotid artery structure in older French adults: the Three-City Study. Stroke35, 2770–2775 (2004).
  • Facchini F, Chen YD, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care17, 115–119 (1994).
  • Laaksonen DE, Nyyssonen K, Niskanen L, Rissanen TH, Salonen JT. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch. Intern. Med.165, 193–199 (2005).
  • Howard BV, Van Horn L, Hsia J et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative randomized controlled Dietary Modification Trial. JAMA295, 655–666 (2006).
  • Zock PL, Katan MB. Trans fatty acids, lipoproteins, and coronary risk. Can. J. Physiol. Pharmacol.75, 211–216 (1997).
  • Mozaffarian D, Pischon T, Hankinson SE et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr.79, 606–612 (2004).
  • Lopez-Garcia E, Schulze MB, Meigs JB et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr.135, 562–566 (2005).
  • Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am. J. Clin. Nutr.79, 969–973 (2004).
  • Keogh JB, Grieger JA, Noakes M, Clifton PM. Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler. Thromb. Vasc. Biol.25, 1274–1279 (2005).
  • de Roos NM, Bots ML, Katan MB. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler. Thromb. Vasc. Biol.21, 1233–1237 (2001).
  • Lin J, Yang R, Tarr PT et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β coactivation of SREBP. Cell120, 261–273 (2005).
  • Daviglus ML, Stamler J, Orencia AJ et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med.336, 1046–1053 (1997).
  • Wang C, Chung M, Lichtenstein A et al. Effects of omega-3 fatty acids on cardiovascular disease – summary, evidence report/technology assessment. Evid. Rep. Technol. Assess.94, 1–8 (2004).
  • GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet354, 447–455 (1999).
  • Marchioli R, Barzi F, Bomba E et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation105, 1897–1903 (2002).
  • Kratz M, Gulbahce E, von Eckardstein A et al. Dietary mono- and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J. Nutr.132, 715–718 (2002).
  • Vega-Lopez S, Kaul N, Devaraj S, Cai RY, German B, Jialal I. Supplementation with ω3 polyunsaturated fatty acids and all-rac α-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism53, 236–240 (2004).
  • Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J. Nutr.134, 2991–2997 (2004).
  • Goode GK, Garcia S, Heagerty AM. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. Circulation96, 2802–2807 (1997).
  • de Lorgeril M, Salen P, Guiraud A, Zeghichi S, Boucher F, de Leiris J. Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in patients with coronary heart disease. Nutr. Metab. Cardiovasc. Dis.15, 36–41 (2005).
  • Risè P, Pazzucconi F, Sirtori CR, Galli C. Statins enhance arachidonic acid synthesis in hypercholesterolemic patients. Nutr. Metab. Cardiovasc. Dis.11, 88–94 (2001).
  • Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch. Intern. Med.162, 1382–1387 (2002).
  • Ros E, Nunez I, Perez-Heras A et al. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation109, 1609–1614 (2004).
  • Jenkins DJ, Kendall CW, Marchie A et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA290, 502–510 (2003).
  • Jenkins DJ, Kendall CW, Marchie A et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am. J. Clin. Nutr.81, 380–387 (2005).
  • Jenkins DJ, Kendall CW, Marchie A et al. Direct comparison of dietary portfolio vs statin on C-reactive protein. Eur. J. Clin. Nutr.59, 851–860 (2005).
  • Jenkins DJ, Kendall CW, Faulkner DA et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am. J. Clin. Nutr.83, 582–591 (2006).
  • Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler. Thromb. Vasc. Biol.21, 968–970 (2001).
  • Lamarche B, Desroches S, Archer WR et al. C-reactive protein levels predict the lipid and lipoprotein response to dietary interventions. Presented at the 2nd International Symposium on Triglycerides and HDL – role in cardiovascular disease and the metabolic syndrome, New York, NY, USA (2005).
  • Williams PT, Blanche PJ, Rawlings R, Krauss RM. Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels. Am. J. Clin. Nutr.82, 181–187 (2005).
  • Levantesi G, Macchia A, Marfisi R et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J. Am. Coll. Cardiol.46, 277–283 (2005).
  • Moore LL, Visioni AJ, Qureshi MM, Bradlee ML, Ellison RC, D’Agostino R. Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. Arch. Intern. Med.165, 1298–1303 (2005).
  • Corton JC, Apte U, Anderson SP et al. Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors. J. Biol. Chem.279, 46204–46212 (2004).
  • Taggart AK, Kero J, Gan X et al. (D)-β-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J. Biol. Chem.280, 26649–26652 (2005).

Website

  • FDA announces qualified health claims for omega-3 fatty acids – September 8, 2004. www.fda.gov/bbs/topics/news/2004/NEW01115.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.